Literature DB >> 2140852

Virus entry and antigen biosynthesis in the processing and presentation of class-II MHC-restricted T-cell determinants of influenza virus.

C J Hackett1, L C Eisenlohr.   

Abstract

Receptor-mediated uptake of influenza virus is responsible for efficient introduction of virus particles to APC. This leads to the effective presentation to T-cells of very small concentrations of proteins entering on the intact virus. Endocytosed virus transits rapidly to the endosome compartment. Entry into this environment appears to greatly affect the fate of T-cell determinants. While promoting the presentation of determinants which require extensive antigen processing, the intracellular environment appears also to lead to destruction of labile determinants, such as those of NA. The same NA determinants are efficiently presented by actively infected cells, indicating that newly biosynthesized viral proteins need not be subjected to the same handling as internalized viral particles. In a similar way, site 3 of HA, which, in a single pulse of noninfectious virus or isolated HA protein is expressed with a relatively short half-life, has greatly improved levels of duration and expression on actively infected APC. Since certain T(H) determinants are unavailable or poorly expressed when introduced on nonreplicative influenza virus, vaccination with inactivated virus might have limitations in stimulating T(H) as well as class-I responses. Finally, individual T-cell determinants of the same protein can exhibit distinct patterns of expression and persistence on APC surfaces. These different half-lives of T(H) determinants may be influential in determining immuno-dominance of T-cell sites. Determinants that are longer-lived on APC may have a greater probability of interacting with appropriate T(H) precursors, which could lead to an enhanced T-cell response to that region of the viral protein.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2140852     DOI: 10.1007/bf02918201

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  62 in total

1.  Activation of influenza A viruses by trypsin treatment.

Authors:  H D Klenk; R Rott; M Orlich; J Blödorn
Journal:  Virology       Date:  1975-12       Impact factor: 3.616

2.  The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides.

Authors:  S Buus; A Sette; S M Colon; C Miles; H M Grey
Journal:  Science       Date:  1987-03-13       Impact factor: 47.728

3.  A group-specific inhibitor of lysosomal cysteine proteinases selectively inhibits both proteolytic degradation and presentation of the antigen dinitrophenyl-poly-L-lysine by guinea pig accessory cells to T cells.

Authors:  S Buus; O Werdelin
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

4.  Antigen processing.

Authors: 
Journal:  Immunol Rev       Date:  1988-12       Impact factor: 12.988

5.  Antigen presentation by a B-cell line transfected with cloned immunoglobulin heavy- and light-chain genes specific for a defined hapten.

Authors:  M Watanabe; D R Wegmann; A Ochi; N Hozumi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

Review 6.  Antigen presenting cells and mechanisms of antigen presentation.

Authors:  R W Chesnut; H M Grey
Journal:  Crit Rev Immunol       Date:  1985       Impact factor: 2.214

7.  Recognition of influenza virus hemagglutinin by subtype-specific and cross-reactive proliferative T cells: contribution of HA1 and HA2 polypeptide chains.

Authors:  J M Katz; W G Laver; D O White; E M Anders
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

8.  Antigen form influences induction and frequency of influenza-specific class I and class II MHC-restricted cytolytic T lymphocytes.

Authors:  L A Morrison; V L Braciale; T J Braciale
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

9.  Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen.

Authors:  A Townsend; J Bastin; K Gould; G Brownlee; M Andrew; B Coupar; D Boyle; S Chan; G Smith
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

10.  Influenza virus site recognized by a murine helper T cell specific for H1 strains. Localization to a nine amino acid sequence in the hemagglutinin molecule.

Authors:  C J Hackett; B Dietzschold; W Gerhard; B Ghrist; R Knorr; D Gillessen; F Melchers
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Influenza vaccine responses in older adults.

Authors:  Janet E McElhaney
Journal:  Ageing Res Rev       Date:  2010-11-03       Impact factor: 10.895

2.  Influenza vaccination in the elderly: seeking new correlates of protection and improved vaccines.

Authors:  Janet E McElhaney
Journal:  Aging health       Date:  2008-12-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.